Treating the Burden of Neonatal Seizures: the UW Experience - Andrew Knox, MD
MD, medical students, PhD (faculty, post-docs) graduate students, Researchers and Scientists, MDPhDs, DO, NPs, PAs, RN, APRN, Psychologists, Faculty and resident specialties including neurology (adult and pediatric neurology, neuropsychology), neurosurgery, neuroradiology, interventional neuroradiology, developmental pediatrics.
Upon completion of this activity, participants will be able to:
- Outline differences between neonatal seizures and seizures at other ages.
- Explain the relationship between neonatal seizures and adverse neurodevelopmental outcomes.
- Make a distinction between presence of neonatal seizures and seizure burden.
- Describe potential adverse effects of phenobarbital exposure in the neonatal period.
- Summarize data from previous studies supporting the efficacy of phenobarbital and levetiracetam.
- Compare data from previous studies to outcomes of patients treated for neonatal seizures at UW.
It is the policy of the University of Wisconsin–Madison Interprofessional Continuing Education Partnership (ICEP) to identify, mitigate and disclose all relevant financial relationships with ineligible companies* held by the speakers/presenters, authors, planners, and other persons who may influence content of this accredited continuing education (CE). In addition, speakers, presenters and authors must disclose any planned discussion of unlabeled/unapproved uses of drugs or devices during their presentation.
* Ineligible companies are those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on, patients.
The ACCME does not consider providers of clinical services directly to patients to be ineligible companies.
For this accredited continuing educational activity all relevant financial relationships have been mitigated and detailed disclosures are listed below:
|In support of improving patient care, the University of Wisconsin–Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.|
Credit Designation Statements
American Medical Association
The University of Wisconsin–Madison ICEP designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Continuing Education Units
The University of Wisconsin–Madison, as a member of the University Continuing Education Association (UCEA), authorizes this program for .1 continuing education units (CEUs) or 1 hour.
- 1.00 AMA PRA Category 1 Credit™
- 1.00 University of Wisconsin–Madison Continuing Education Hours
- 1.00 Approved for AMA PRA Category 1 Credit™
QUESTIONS ABOUT REGISTRATION
The University of Wisconsin provides equal opportunities in employment and programming, including Title IX requirements. The University of Wisconsin fully complies with the legal requirements of the ADA and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please notify us at firstname.lastname@example.org
Computer, tablet, or other mobile device with sound.
Free, current version of Edge, Firefox, Safari, or Chrome. Some older browsers and Internet Explorer could produce error messages or not display the content correctly.
Free, current version of Adobe Acrobat Reader or other .pdf reader.